INNOVATE's MediBeacon TGFR System nominated for 2026 Prix Galien USA Best Medical Technology

INNOVATE Corp.

MediBeacon TGFR System nominated for 2026 Prix Galien USA Best Medical Technology by The Galien Foundation.
Winners announced Oct 29, 2026 at American Museum of Natural History in New York City.
TGFR System is first-in-kind point-of-care kidney function assessment using Lumitrace injection, monitor, and reusable sensor.
Earlier in 2026, JASN recognized a transdermal GFR assessment article as one of five Editor's Choice articles of 2025.
MediBeacon is an equity method investment of INNOVATE (NYSE: VATE).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.